The CDHR3 gene helps make a protein on the surface of cells lining the airways, where it supports the airway lining. If this gene does not work as expected, that lining may be more vulnerable, and some variants can make it easier for rhinovirus C, a common cold virus, to enter those cells. This gene can play a role in how your body responds to chest colds, wheezing, and asthma flare ups. Many carrying this gene change never develop asthma, but some have a higher chance of repeated breathing symptoms, especially in childhood.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes provide the instructions for producing proteins, which are the working parts of cells. Others mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
CDHR3Gene function
What if the gene works
The CDHR3 gene helps cells lining the airways stick together and support tiny cilia, the hairlike structures that move mucus. This helps keep breathing passages clearer and supports normal lung defense.
Risk
What if the gene does not work
Certain variants in the CDHR3 gene can raise susceptibility to rhinovirus C infections and childhood wheezing or asthma flare-ups. Milder and more disruptive variants may affect how airway lining cells respond, influencing whether symptoms appear and how severe they are.
Treatment
What does that mean for your treatment
At present, no treatment or drug choice approach based on the CDHR3 gene is established in clinical guidelines. The CDHR3 gene is being studied as a biomarker and possible treatment target because some variants can affect how easily rhinovirus C enters airway cells, which may shape wheezing or asthma flare patterns.
Gene function
What if the gene works
One of the main jobs of the CDHR3 gene in the airways is helping surface cells stay connected and well arranged. It is most active in the cells lining the nose and lungs, especially ciliated cells. When it works as expected, it supports a smooth airway surface that handles everyday breathing and routine clearing of mucus and particles.
The CDHR3 gene helps neighboring airway cells hold onto each other at their surface. Its protein uses calcium, a mineral in body fluids, to help those contacts stay steady.
Protein made from the CDHR3 gene is most abundant in ciliated cells, the cells with tiny moving hairs that help move mucus. This supports the orderly layout of the airway lining so the surface stays even and well organized.
In airway lining cells, the CDHR3 protein sits on the outer surface where cells meet. That placement supports a smooth, specialized lining that can carry out everyday cleaning and protective work.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can more significantly change how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the CDHR3 gene can alter how much CDHR3 reaches the cell surface and how stable it remains there. A well-studied variant, p.Cys529Tyr, increases surface levels of the protein and makes it easier for rhinovirus C to attach, helping explain how CDHR3 gene variants can influence childhood wheezing and asthma risk. Other variants may have milder effects on trafficking or stability, while more disruptive variants can leave much less working protein at the cell surface.
How variants are linked to conditions
Variants in the CDHR3 gene are most clearly linked to a higher chance of severe wheezing illnesses and asthma flare ups in young children, especially during rhinovirus C colds. The best studied finding is that one common CDHR3 variant is associated with severe childhood asthma attacks in several populations, but it does not mean a child will develop asthma. Research also supports a role for the CDHR3 gene in recurrent early life breathing illnesses.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a routine part of human biology. Most do not directly affect health and simply contribute to normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. Still, in some situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CDHR3, the clearest risk change seen so far is a higher chance of wheezing illnesses and severe asthma flare-ups in children after infections with rhinovirus C, a common cold virus. This risk appears to depend mainly on the specific CDHR3 variant a child carries, together with exposure to that virus.
Inheritance of CDHR3 variants
There is not yet a broadly confirmed Mendelian inheritance pattern for the CDHR3 gene tied to a single well-defined CDHR3-related condition. Most attention has focused on common CDHR3 gene variants that may influence a person’s tendency toward wheezing illnesses, rhinovirus C infections, or asthma flare-ups, rather than causing a classic inherited syndrome with a set dominant or recessive pattern. For families asking about the inheritance pattern of CDHR3 variants, the key point is that the CDHR3 gene sits on chromosome 7, which is an autosome, so each person inherits one copy from each parent.
What does my CDHR3 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific single-gene condition for CDHR3. Some CDHR3 changes have been linked with a higher chance of wheezing illnesses and asthma flare-ups, but these findings do not mean relatives will definitely have the same health issues. If you have a specific CDHR3 result and want to understand what it could mean for your family, a doctor or genetic counselor can help explain it in context.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CDHR3 variants usually uses a saliva sample or blood sample to read your DNA. A lab may examine the CDHR3 gene on its own, as part of a panel, or through exome or genome sequencing. Results can show whether a variant is present, but they do not on their own predict symptoms or confirm lung disease.
When should I consider getting a genetic test?
CDHR3 changes have been linked with a higher chance of some childhood wheezing and asthma flare-ups, but there is not a broadly established reason to order CDHR3 testing on its own. Decisions about testing are usually based on the bigger picture of symptoms and family history, ideally with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person but not as well for another. These differences are common and can influence both how well a medicine works and the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It studies gene and drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes can influence how powerfully a drug works or how the body handles it. This understanding can support more informed, more individualized treatment decisions. To learn more about this topic, more information is available in the LearnHub.
Drugs influenced by the CDHR3 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication response. If you have questions about medicines, side effects, or changes in breathing symptoms, talk with your doctor.
History
The CDHR3 gene came into focus as researchers worked to explain why some children were more prone to severe wheezing illnesses and asthma flare-ups. In 2015, studies identified a CDHR3 variant linked to a higher chance of severe childhood asthma attacks, especially those tied to viral infections. Building on this early work, scientists also showed that CDHR3 was the long-sought entry point used by rhinovirus C, a common trigger for colds that can hit the lungs hard in some children. That finding helped connect genetic risk with a specific infection pathway. Since then, CDHR3 has become an important gene in research on childhood asthma and virus-related breathing problems.